Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138783 · ClinicalTrials.gov registry record · NA
Clinical Performance of Two Daily Disposable Soft Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT05138783: Completed NA study, sponsored by Alcon Research.
NCT05138783 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 129 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138783, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical performance of PRECISION1 contact lenses with Biotrue contact lenses.
Primary Outcome
Visual Acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm of the minimum angle of resolution (logMAR). A logMAR value of 0 corresponds to 20/20 Snellen acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Interventions
- DEVICE Verofilcon A contact lenses
- DEVICE Nesofilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2022-01-12 |
| Est. Completion | 2022-03-07 |
| Phase | NA |
What the finished NCT05138783 record still lists
NCT05138783 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Verofilcon A contact lenses is the first listed.
NCT05138783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05138783 about?
NCT05138783 is a clinical study titled "Clinical Performance of Two Daily Disposable Soft Contact Lenses". The purpose of this study is to compare the clinical performance of PRECISION1 contact lenses with Biotrue contact lenses.
What is the current status of trial NCT05138783?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2022-01-12. Estimated completion is 2022-03-07.
What interventions are being tested in trial NCT05138783?
The interventions under investigation include: Verofilcon A contact lenses (DEVICE), Nesofilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05138783?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05138783's enrollment target sits among peer trials
129 744th of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI